BE896027A - Nouvelles glycoproteines, procedes de production et agents therapeutiques pour le traitement de tumeurs en contenant - Google Patents

Nouvelles glycoproteines, procedes de production et agents therapeutiques pour le traitement de tumeurs en contenant

Info

Publication number
BE896027A
BE896027A BE210211A BE210211A BE896027A BE 896027 A BE896027 A BE 896027A BE 210211 A BE210211 A BE 210211A BE 210211 A BE210211 A BE 210211A BE 896027 A BE896027 A BE 896027A
Authority
BE
Belgium
Prior art keywords
treatment
same
therapeutic agents
production methods
tumors containing
Prior art date
Application number
BE210211A
Other languages
English (en)
Original Assignee
Mochida Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP57028993A external-priority patent/JPS58146293A/ja
Priority claimed from JP57028992A external-priority patent/JPS58148826A/ja
Priority claimed from JP57087674A external-priority patent/JPS58203917A/ja
Priority claimed from JP57087675A external-priority patent/JPS58203918A/ja
Priority claimed from JP57108046A external-priority patent/JPS58225024A/ja
Application filed by Mochida Pharm Co Ltd filed Critical Mochida Pharm Co Ltd
Publication of BE896027A publication Critical patent/BE896027A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BE210211A 1982-02-26 1983-02-25 Nouvelles glycoproteines, procedes de production et agents therapeutiques pour le traitement de tumeurs en contenant BE896027A (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP57028993A JPS58146293A (ja) 1982-02-26 1982-02-26 抗腫瘍性糖蛋白質の製造方法
JP57028992A JPS58148826A (ja) 1982-02-26 1982-02-26 糖蛋白質および腫瘍治療剤
JP57087674A JPS58203917A (ja) 1982-05-24 1982-05-24 糖蛋白質およびその製法ならびに腫瘍治療剤
JP57087675A JPS58203918A (ja) 1982-05-24 1982-05-24 糖蛋白質およびその製造法ならびに腫瘍治療剤
JP57108046A JPS58225024A (ja) 1982-06-23 1982-06-23 糖蛋白質およびその製造方法ならびに腫瘍治療剤

Publications (1)

Publication Number Publication Date
BE896027A true BE896027A (fr) 1983-08-25

Family

ID=27521092

Family Applications (1)

Application Number Title Priority Date Filing Date
BE210211A BE896027A (fr) 1982-02-26 1983-02-25 Nouvelles glycoproteines, procedes de production et agents therapeutiques pour le traitement de tumeurs en contenant

Country Status (17)

Country Link
US (1) US4481137A (fr)
BE (1) BE896027A (fr)
BR (1) BR8300933A (fr)
DD (1) DD209634A5 (fr)
DE (1) DE3306297A1 (fr)
DK (1) DK93383A (fr)
FI (1) FI830638L (fr)
FR (1) FR2522267A1 (fr)
GB (1) GB2117385B (fr)
GR (1) GR78097B (fr)
LU (1) LU84662A1 (fr)
NL (1) NL8300727A (fr)
NO (1) NO830669L (fr)
PL (1) PL240784A1 (fr)
PT (1) PT76296B (fr)
RO (1) RO85901B (fr)
SE (1) SE8301073L (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920196A (en) * 1982-07-30 1990-04-24 Genentech, Inc. Human lymphotoxin
DE3334405A1 (de) * 1983-09-23 1985-04-04 Behringwerke Ag, 3550 Marburg Membranassoziierte proteine (mp(pfeil abwaerts)2(pfeil abwaerts)), verfahren zu ihrer gewinnung sowie ihre verwendung
JPS60112718A (ja) * 1983-11-21 1985-06-19 Kyorin Pharmaceut Co Ltd 抗腫瘍作用を示す蛋白性物質及びその製造方法
US4758549A (en) * 1983-12-13 1988-07-19 Kabushiki Kaisha Mayashibara Seibutsu Kagaku Kenkyujo Lymphokine, monoclonal antibody specific to the lymphokine and their production and uses
US4879226A (en) * 1984-04-06 1989-11-07 Asahi Kasei Kogyo Kabushiki Kaisha Novel human physiologically active polypeptide
US5683688A (en) * 1984-05-31 1997-11-04 Genentech, Inc. Unglycosylated recombinant human lymphotoxin polypeptides and compositions
US4959457A (en) * 1984-05-31 1990-09-25 Genentech, Inc. Anti-lymphotoxin
US5672347A (en) * 1984-07-05 1997-09-30 Genentech, Inc. Tumor necrosis factor antagonists and their use
US6686455B1 (en) 1984-07-05 2004-02-03 Genentech, Inc. Tumor necrosis factor
FR2568125B1 (fr) * 1984-07-25 1988-04-15 Kogo Michiko Agent anti-tumeur contenant la proteine du sucre
US5019385A (en) * 1984-11-09 1991-05-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Novel lymphopine LK 2 and pharmaceutic compositions containing same
JPH0631318B2 (ja) * 1985-09-18 1994-04-27 株式会社林原生物化学研究所 新リンホカインｉｉｉとその製法
US4822605A (en) * 1986-02-18 1989-04-18 Exovir, Inc. Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like
EP0378676A4 (en) * 1988-07-15 1991-01-16 The Trustees Of Columbia University In The City Of New York Tumor necrosis enhancing factor and methods of preparation and use
US5106745A (en) * 1989-12-06 1992-04-21 Board Of Regents, The University Of Texas System Broad spectrum virus inhibitor, UTI-β
JP3552240B2 (ja) * 1993-02-23 2004-08-11 第一製薬株式会社 高濃度ｔｃｆ製剤
US5641867A (en) * 1993-09-29 1997-06-24 The Trustees Of Columbia University In The City Of New York Antibody which specifically binds to endothelial-monocyte activating polypeptide II
JP4006058B2 (ja) * 1997-03-11 2007-11-14 第一三共株式会社 多臓器不全予防及び／又は治療剤
ATE344050T1 (de) * 1997-03-14 2006-11-15 Daiichi Seiyaku Co Verwendung von tcf-ii zur behandlung von durch krebs verursachtem gewichtsverlust, anaemie und tnf-erhöhung
BG65084B1 (bg) * 2002-03-13 2007-02-28 Закрьiтое Акционерное Общество, Производственное Предприятие"Эндо-Фарм-А" Нов клас биоактивни гликопротеини
US20120077206A1 (en) 2003-07-12 2012-03-29 Accelr8 Technology Corporation Rapid Microbial Detection and Antimicrobial Susceptibility Testing
EP1648286B1 (fr) * 2003-07-12 2017-12-20 Accelerate Diagnostics, Inc. Biodetection sensible et rapide
US7341841B2 (en) * 2003-07-12 2008-03-11 Accelr8 Technology Corporation Rapid microbial detection and antimicrobial susceptibility testing
US10254204B2 (en) 2011-03-07 2019-04-09 Accelerate Diagnostics, Inc. Membrane-assisted purification
US9434937B2 (en) 2011-03-07 2016-09-06 Accelerate Diagnostics, Inc. Rapid cell purification systems
US9677109B2 (en) 2013-03-15 2017-06-13 Accelerate Diagnostics, Inc. Rapid determination of microbial growth and antimicrobial susceptibility
US10253355B2 (en) 2015-03-30 2019-04-09 Accelerate Diagnostics, Inc. Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing
WO2016161022A2 (fr) 2015-03-30 2016-10-06 Accerlate Diagnostics, Inc. Instrument et système pour l'identification rapide de micro-organismes et test de la sensibilité à un agent antimicrobien

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2726886A1 (de) * 1977-06-15 1979-01-18 Behringwerke Ag Neues glykoprotein und verfahren zu dessen herstellung
JPS6030291B2 (ja) * 1978-03-20 1985-07-16 森永乳業株式会社 人顆粒球の分化増殖を促進するｈｇｉ糖蛋白質、ｈｇｉ糖蛋白質の製造法及びｈｇｉ糖蛋白質を含有する白血球減少症治療剤
US4261976A (en) * 1978-10-03 1981-04-14 The Massachusetts General Hospital Method and glycoprotein composition for inhibition of growth of transformed cells and tumors
US4243582A (en) * 1979-04-26 1981-01-06 Monsanto Company Novel glycoproteins from bovine cartilage

Also Published As

Publication number Publication date
GB2117385A (en) 1983-10-12
FI830638A0 (fi) 1983-02-25
PT76296A (en) 1983-03-01
GR78097B (fr) 1984-09-26
PT76296B (en) 1985-11-12
RO85901B (ro) 1985-01-30
SE8301073L (sv) 1983-08-27
RO85901A (fr) 1985-01-24
NO830669L (no) 1983-08-29
DK93383A (da) 1983-08-27
BR8300933A (pt) 1983-11-16
FR2522267A1 (fr) 1983-09-02
NL8300727A (nl) 1983-09-16
PL240784A1 (en) 1983-11-07
DD209634A5 (de) 1984-05-16
DK93383D0 (da) 1983-02-25
US4481137A (en) 1984-11-06
LU84662A1 (fr) 1983-09-08
DE3306297A1 (de) 1983-09-15
GB2117385B (en) 1985-05-09
SE8301073D0 (sv) 1983-02-25
FI830638L (fi) 1983-08-27
GB8305330D0 (en) 1983-03-30

Similar Documents

Publication Publication Date Title
BE896027A (fr) Nouvelles glycoproteines, procedes de production et agents therapeutiques pour le traitement de tumeurs en contenant
IT1193395B (it) Complessi platino-diamminici e formulazioni farmaceutiche per il trattamento del cancro che li contengono
MA18939A1 (fr) Procede de preparation d'un agent pour le traitement de theilerioses
BE837662A (fr) Composition gelifiee contenant de la tretinoine pour le traitement de l'acne
FR2565493B1 (fr) Appareil d'electrotherapie, pour le traitement du cuir chevelu
BE890433A (fr) Composition cosmetique pour le traitement local de la cellulite
FR2556956B3 (fr) Prothese penienne semi-rigide pour le traitement des impuissances d'erection
BE852095A (fr) Composition pharmaceutique pour le traitement de la leucemie et de tumeurs
FR2558372B1 (fr) Composition medicamenteuse pour le traitement de l'acne
BE858692A (fr) Composition pour le traitement de l'acne
BE856957A (fr) Electrode pour traitement d'ionophorese
RO79428A2 (fr) Composition medicamenteuse pour le traitement des dermatoses
IT1159815B (it) Composizione medicinale per il trattamento di certe neurovirosi
FR2588756B1 (fr) Composition pour le traitement des cheveux
BE888543A (fr) Procedes et machines pour le traitement de pierres precieuses,
FR2310768A1 (fr) Medicament pour le traitement de l'alopecia senilis
RO65965A2 (fr) Composition medicamenteuse pour le traitement d'ulcere gastroduodenel
FR2536280B1 (fr) Composition pharmaceutique et procede pour le traitement de tumeurs
FR2517203B1 (fr) Composition pour le traitement de l'acne
BE860239A (fr) Preparation medicinale pour le traitement des neoformations malignes
FI831258L (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara benzimidazolderivat
RO89432A2 (fr) Composition medicamenteuse pour le traitement du cancer
RO79211A2 (fr) Composition medicamenteuse pour le traitement de psoriazise
RO86650A2 (fr) Prepare pharmaceutique pour le traitement des dermatoses
RO79926A2 (fr) Composition medicamenteuse pour le traitement des hemorroides

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: MOCHIDA PHARMACEUTICAL CO. LTD

Effective date: 19850225